Presentation is loading. Please wait.

Presentation is loading. Please wait.

FDA Update Randy Levin, MD and William A. Hess, CAPT USPHS HL7 16th Annual Working Group Meeting Baltimore, MD October 2002.

Similar presentations


Presentation on theme: "FDA Update Randy Levin, MD and William A. Hess, CAPT USPHS HL7 16th Annual Working Group Meeting Baltimore, MD October 2002."— Presentation transcript:

1 FDA Update Randy Levin, MD and William A. Hess, CAPT USPHS HL7 16th Annual Working Group Meeting Baltimore, MD October 2002

2 FDA Update New Ingredient Dictionary Pharmaceutical Dosage Forms E2BM Data Elements Labeling Effort NDC

3 FDA Update New Ingredient Dictionary History Need Collaboration Design Non-structures

4 FDA Update New Ingredient Dictionary History Original Ingredient Dictionary two tables no structures (WLN) no processes non-random identifier mostly drugs, some biologics

5 FDA Update New Ingredient Dictionary Need searchable structures describe processes (vaccines) randomly assigned unique identifier drugs, biologics, foods, natural products, devices

6 FDA Update New Ingredient Dictionary Collaboration FDA NLM HL7 NCI Others

7 FDA Update New Ingredient Dictionary Design Architecture Platform: Active Server Pages (ASP) running on Microsoft Internet Information Server (IIS) Scripting language: JavaScript, for special processing and navigation Database: A standard RCG chemical database, set up using MDL tools, with fields allocated for needed extra data (see Data Model, below). This database runs on an Oracle platform. Database access: ActiveX Data Objects (ADO) MDL Software: ISIS/Direct 2.0, for access to stored structures using SQL commands ChimePro 2.6, for visual rendering of molecular structures ISIS/Draw 2.4, for creating and editing molecular structures Autonom 2000 TT, for generating IUPAC names Other Software: Visual Basic 6.0 run time DLLs, for Autonom support Browser: Microsoft Internet Explorer 5.x

8 FDA Update New Ingredient Dictionary Design Data Model Structure: A binary field containing the chemical structure, in MDL standard molecule format. Structures will be represented in two dimensions. MDLNum: An alphanumeric string that will identify each unique structure in the database. It should have at least 9 characters, and should be generated non- sequentially, such that two consecutively-generated numbers are not related. BDNum: An alphanumeric identifier that will link each compound to the associated chemical in CDER's current Ingredient Dictionary. This field may be blank. A BDNum may be associated with more than one MDLNum. Name: A text field, of 240 characters, that will contain the chemical name. OR Group: An integer field that is associated with each structure in a mixture. If two or more structures in a mixture have the same OR Group number, at least one of them is present in the mixture.

9 FDA Update New Ingredient Dictionary Design Data Model

10 FDA Update New Ingredient Dictionary Screen Design Logo Please enter search criteria Search Structure MDL Number Name BD Number Structure MDLNum BDNum Type Name A8VIERA3F AA Structure Neomorphine 8C9KSKL AA Structure Pseudomorphine Zoom Records 6 through 10 of 19 > GK934KF1S AA Mixture Conjugated Estrogens Search Register Structure Register Mixture

11 FDA Update New Ingredient Dictionary Non-structures Gelatin Vaccines Plants (e.g., oregano)

12 FDA Update New Ingredient Dictionary Non-structures VSWG being formed Mostly FDA Advisors from Other Organizations Ground-rule development

13 FDA Update New Ingredient Dictionary Questions and Comments

14 FDA Update Pharmaceutical Dosage Forms Initial HL7 terms Australian and U.S. collaboration Ordering Definitions

15 FDA Update E2BM Data Elements Data Elements for the Transmission of Individual Case Safety Reports International Conference on Harmonisation

16 FDA Update E2BM Data Elements Seriousness criteria (death, life threatening, etc) Qualification (physician, pharmacist, etc) Study Type (clinical trials, etc) Sender type (Pharmaceutical Company, Health Professional, etc) Receiver Type (similar to above) Patient Age Group (Neonate, Infant, etc) Outcome ( Recovered/Resolved, Fatal, etc) Characterization of Drug Role (Suspect, Interacting, etc) Actions Taken with Drug (Dose Reduced, Drug Withdrawn, etc)

17 FDA Update Labeling Effort Bar-coded Products Hand-held Bar-code Scanner Viewpad Reformatted labels (8.5x11)

18 FDA Update Labeling Effort

19 FDA Update Labeling Effort

20 FDA Update National Drug Code (NDC) Background Problems Sufficiency Possible Solutions

21 Background FDA Update National Drug Code (NDC)

22 The NDC was originally established as a voluntary essential part of out-of-hospital reimbursement program under Medicare in the late1960s. Original Audience: Medicare FDA Update National Drug Code (NDC)

23 FDA Update National Drug Code (NDC) The NDC has expanded to include a number of additional functions These functions are beyond the original purpose of the NDC Significant deficiencies for the effectiveness of the NDC as an identifier even for the packaged product Current processes for creating and maintaining the NDC is imperfect

24 FDA Update National Drug Code (NDC)

25 Problems FDA Update National Drug Code (NDC)

26 FDA Update National Drug Code (NDC) Basic Problems with the NDC as a robust identifier NDC consists of three different codes separated by hyphens NDC format design allows companies to independently assign NDC The lack of control leads to reliability problems

27 Problem 1: Labeler Code Companies could have more than one labeler code. When companies change, such as through a merger or split, the labeler code does not necessarily change. FDA Update National Drug Code (NDC)

28 The labeler code is assigned by the FDA when a person who owns or operates any establishment registers their establishment FDA Update National Drug Code (NDC)

29 Problem 2: Product Code Product code is not controlled. More than one product code can be assigned to the same drug formulation. FDA Update National Drug Code (NDC)

30 The product code assigned by the person who owns or operates any establishment. Product codes have either 3 or 4 digits FDA Update National Drug Code (NDC)

31 Even within the same company, a single product code can represent two different drug formulation because the company may have two different labeler codes. A product code should not be relied on as a unique identifier for a drug formulation even with a within a single company or a single labeler code. FDA Update National Drug Code (NDC)

32 Problem 3: Package Code As with the product code, the package code is not controlled. FDA Update National Drug Code (NDC)

33 The package code is also assigned by the person who owns or operates any establishment. Package codes have either 1 or 2 digits FDA Update National Drug Code (NDC)

34 Problem 4: NDC lacks a standardized form The NDC is a standard but is not standardized. It consists of three codes separated by hyphens for a total of 10 digits. Because of differences in the length of the three codes, the NDC can be in one of three formats: 5-4-1, or FDA Update National Drug Code (NDC)

35 Frequently the NDC is stored in a normalized 11 digit format of by padding the short code with an extra zero. This changes the actual number if the hyphens are removed such as for use in bar coding. FDA Update National Drug Code (NDC)

36 For example, if we pad the short code, so that we always have a configuration, then: (4-4-2 configuration) becomes (5-3-2 configuration) becomes (5-4-1 configuration) becomes FDA Update National Drug Code (NDC)

37 ...and then remove the hyphens, we get FDA Update National Drug Code (NDC)

38 Problem 5: NDC is not a unique identifier for bar codes NDC hyphens cannot be removed without potentially introducing redundant codes. NDC relies on the separation of the three codes to maintain its uniqueness FDA Update National Drug Code (NDC)

39 Each 10 digit number can have up to three NDC codes. For example, represents: (4-4-2 configuration) (5-3-2 configuration) (5-4-1 configuration) FDA Update National Drug Code (NDC)

40 Problem 6: An NDC can be reused The labeler code can be reused after a firm has been out of business for at least 5 years. The product code for a discontinued product can be reused 5 years after the expiration date or after the last shipment, if no expiration date. This means the NDC lacks permanence and is not unique for a specific package product. FDA Update National Drug Code (NDC)

41 Problem 7: Lack of a complete, up to date valid list FDA Update National Drug Code (NDC) The FDA does not have an up to date, or complete, list of all NDC used on packaged products. Since the companies assign their own NDC, the FDA must rely on the companies to tell them when they have assigned a new number.

42 A company might not inform the FDA of a new NDC for months, if at all, after it is being used. Most people who use the NDC receive the list of codes from third parties and not from the FDA. This results in products being included that are not legally marketed drugs. FDA Update National Drug Code (NDC)

43 This demonstrates that while the individual codes in the NDC appears to have meaning, the controls on these individual codes are not sufficient to be reliable. FDA Update National Drug Code (NDC)

44 Sufficiency The NDC, to be a robust identifier for packaged products, should include the following features... FDA Update National Drug Code (NDC)

45 Unique identifier – each NDC should identify only one package product FDA Update National Drug Code (NDC)

46 Comprehensive – there should be one NDC for each packaged product marketed legally marketed in the US FDA Update National Drug Code (NDC)

47 Unambiguous – the NDC should represent only a single concept FDA Update National Drug Code (NDC)

48 Permanence - the NDC should be associated with the same packaged product indefinitely FDA Update National Drug Code (NDC)

49 Non semantic identifier (Meaningless concept identifier, nonsense codes) - the NDC should not be hierarchical allowing for later relocation and multiple classification FDA Update National Drug Code (NDC)

50 Centrally assigned- the NDC should be assigned by a central authority to enforce rules and eliminate invalid codes FDA Update National Drug Code (NDC)

51 Publication and distribution by central authority – a complete and up to date list of all valid NDC should be published and freely distributed to all users FDA Update National Drug Code (NDC)

52 Non proprietary – the NDC should be free for all users FDA Update National Drug Code (NDC)

53 Timely assignment – a new NDC should be available in a timely manner as not to unreasonably slow the movement of products to the market FDA Update National Drug Code (NDC)

54 Automated management – the assignment and maintenance of the NDC should be automated to reduce costs and improve efficiency FDA Update National Drug Code (NDC)

55 Works with bar codes – the NDC should work with current bar code technology FDA Update National Drug Code (NDC)

56 Longevity – there should be sufficient codes to allow the NDC to be used in its current state for many years FDA Update National Drug Code (NDC)

57 Possible solutions FDA Update National Drug Code (NDC)

58 Code format Change to a non semantic, unambiguous, standardized code. Maintain current 10 digits allowing NDC to continue to fit into current bar codes and potential future international bar codes systems. Numeric codes alone allow up to 10 billion codes FDA Update National Drug Code (NDC)

59 NDC assignment NDC assigned by FDA as the central authority to oversee that only valid products are assigned codes Assign NDC to products when listed to ensure a complete list of NDC for all marketed packaged products Use automated systems with quality controls to allow timely assignment of standardized codes NDC permanence assured by never deleting codes and not allowing a new code to be assigned to the same product. FDA Update National Drug Code (NDC)

60 Additional codes Create codes for ingredients, clinical drug, and product to fulfill needs not adequately met by the NDC FDA Update National Drug Code (NDC)

61 Distribution NDC freely distributed in FDA/NLM system associated with other useful medication codes and information including: ingredient, product, RxNorm, imprint codes and labeling. FDA Update National Drug Code (NDC)

62 Questions and Comments FDA Update National Drug Code (NDC)

63 The End FDA Update National Drug Code (NDC)


Download ppt "FDA Update Randy Levin, MD and William A. Hess, CAPT USPHS HL7 16th Annual Working Group Meeting Baltimore, MD October 2002."

Similar presentations


Ads by Google